Evidence map›Paper›PMID 36550098›Full record

ArticleCell death & disease2022

Correction to: High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis.

Chen Yang, Zezhong Mou, Siqi Wu, Yuxi Ou, Zheyu Zhang, Xinan Chen, Xiyu Dai, Chenyang Xu, Shanhua Mao, Haowen Jiang

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chen Yang *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China. YangC_Huashan@163.com.
Zezhong Mou *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Siqi Wu *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Yuxi OuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Zheyu ZhangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0003-1907-0765
Xinan ChenDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Xiyu DaiDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Chenyang XuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Shanhua MaoDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China. maoshanhua@163.com.
Haowen JiangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China. haowj_sh@fudan.edu.cn.ORCID http://orcid.org/0000-0002-5349-1363
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36550098
PMCPMC9780318
OpenAlexW4312141275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.